Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: Eexperiences from india

Indian Journal of Medical Research

Volumn 134, Issue 10, 2011, Pages 552-560

  Colah, R B ^a   Gorakshakar, A C ^a   Nadkarni, A H ^a  

^a NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

Author keywords

Haemoglobinopathies; India; Invasive and non; Invasive approaches; Prenatal diagnosis

Indexed keywords

HEMOGLOBIN E; HEMOGLOBIN F; HEMOGLOBIN S;

AMNIOCENTESIS; AMNION FLUID; AMPLIFICATION REFRACTORY MUTATION SYSTEM; BETA DELTABETA THALASSEMIA; BETA THALASSEMIA; BLOOD SAMPLING; CELL ISOLATION; CHORION VILLUS SAMPLING; CODON; CONTROLLED STUDY; CORDOCENTESIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; DOT HYBRIDIZATION; FETUS BLOOD SAMPLING; FETUS CELL; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENE MAPPING; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HEMOGLOBIN E BETA THALASSEMIA; HEMOGLOBIN LEPORE BETA THALASSEMIA; HEMOGLOBIN SD DISEASE; HEMOGLOBINOPATHY; HETEROZYGOTE DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INVASIVE PROCEDURE; MATERNAL BLOOD; MOLECULAR DIAGNOSIS; NEWBORN SCREENING; NON INVASIVE PROCEDURE; NUCLEIC ACID ANALYSIS; PRENATAL DIAGNOSIS; PREVALENCE; REVERSE DOT BLOT HYBRIDIZATION; REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; THALASSEMIA; THALASSEMIA MAJOR;

ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CHORIONIC VILLI SAMPLING; CORDOCENTESIS; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; INDIA; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 80455130137     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Weatherall DJ. The inherited disorders of hemoglobin are an emerging global health burden. Blood 2010; 115: 4331-6.
2. Cao A. Results of programs for antenatal detection of thalassemia in reducing the incidence of the disorder. Blood Rev 1987; 1: 169-76.
3. Angastiniotis MA, Hadjiminas MG. Prevention of thalassemia in Cyprus. Lancet 1991; 1: 369-70.
4. Petrou M, Modell B. Prenatal screening for hemoglobin disorders. Prenat Diagn 1995; 15: 1275-95.
5. Loukopoulos D. Current status of thalassaemia and the sickle cell disorders in Greece. Semin Hematol 1996; 33: 76-86.
6. World Health Organization. Management of hemoglobin disorders, Report of Joint WHO-TIF meeting, Nicosia, Cyprus, 16-18 November, 2007. Geneva: WHO; 2008.
7. Mehta BC, Dave VB, Joshi SR, Baxi AJ, Bhatia HM, Patel JC. Study of hematological and genetical characteristics of Kutchi Bhanushali Community. Indian J Med Res 1972; 60: 305-11.
8. Sukumaran PK. Abnormal hemglobins in India. In: Sen NN, Basu AK, editors. Trends in hematology. Calcutta: Sree Saraswati Press; 1975. p. 225-61.
9. Chouhan DM, Chouhan V. Epidemiology: Symposium on thalassemia. Indian J Hematol Blood Transf 1992; 10: 1-6.
10. Jawahirani A, Mamtani M, Das K, Rughwani V, Kulkarni H. Prevalence of beta thalassemia in sub-castes of Indian Sindhis: Results from a two phase survey. Public Health 2007; 121: 193-8.
11. Mohanty D, Colah R, Gorakshakar A. editors. Report of the Jai Vigyan S & T Mission Project on community control of thalassaemia syndromes- Awareness, screening, genetic counselling and prevention. A National Multicentric Task Force Study of Indian Council of Medical Research, New Delhi; 2008. New Delhi: ICMR; 2008.
12. Madan N, Sharma S, Sood SK, Colah R, Bhatia HM. Frequency of β-thalassemia and other hemoglobinopathies in northern and western India. Indian J Hum Genet 2010; 16: 16-25.
13. Modell B, Petrou M. The problem of hemoglobinopathies in India. Indian J Haematol 1983; 1: 1-5.
14. Choudhry VP, Upadhyay A. Thalassemia screening and control programme. In: Ghosh K, Colah R, editors. Control and management of thalassaemia and other hemoglobinopathies in the Indian subcontinent - Synoptic views. Mumbai: National Institute of Immunohaematology; 2008. p. 36-44.
15. Colah R, Gorakshakar A, Phanasgaonkar S, D'Souza E, Nadkarni A, Surve R, et al. Epidemiology of β-thalassemia in western India:Mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br J Haematol 2010; 149: 739-47.
16. Bhatia HM, Rao VR. Genetic atlas of the Indian tribes. Mumbai: Institute of Immunohaematology; 1986.
17. Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Physicians India 1996; 44: 25-8.
18. Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Haematol 2002; 9: 117-22.
19. Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet 2002; 5: 192-6.
20. Deka R, Reddy AP, Mukherjee BN, Das BM, Banerjee S, Roy M, et al. Hemoglobin E distribution in 10 endogamous population groups of Assam, India. Hum Hered 1988; 38: 261-6.
21. De M, Halder A, Podder S, Sen R, Chakraborty S, Sengupta B, et al. Anemia and hemoglobinopathies in tribal population of eastern and north eastern India. Hematology 2006; 11: 371-3.
22. Sharma SK, Mahanta J. Prevalence of hemoglobin variants in malaria endemic north east India. J Biol Sci 2009; 9: 288-91.
23. Das MK, Dey B, Roy M, Mukherjee BM. High prevalence of Hb E in 3 populations of the Malda district, West Bengal, India. Hum Hered 1991; 41: 84-8.
24. Nadkarni A, Ghosh K, Gorakshakar A, Colah R, Moahtny D. Variable clnical severity of Hb E β-thalassemia among Indians. J Assoc Physicians India 1999; 47: 966-8.
25. Panigrahi I, Agwaral S, Gupta J, Singhal P, Pradhan M. Hemoglobin E beta thalassemia: Factors affecting phenotype. Indian Pediatr 2005; 42: 357-62.
26. Kulozik AE, Bail S, Kar BC, Serjeant BE, Serjeant GR. Sickle cell -β+ thalassemia in Orissa state, India. Br J Haematol 1991; 77: 215-20.
27. Weatherall DJ, Clegg JB. The thalassemia syndromes, 4th ed. Oxford: Blackwell Scientific Publications; 2001.
28. Giambano A, Passarello C, Vinciguerra M, Li Muli R, Teresi P, Anzà M, et al. Significance of borderline HbA2 values in an Italian population with a high prevalence of β-thalassemia. Haematologica 2008; 93: 1380-4.
29. Garewal G, Das R, Awasthi A, Ahluwalia J, Marwaha RK. The clinical significance of the spectrum of interactions of Cap + 1 (A→C), a silent β globin gene mutation with other β thalassemia mutations and globin gene modifiers in north Indians. Eur J Haematol 2007; 79: 417-21.
30. Colah R, Gorakshakar A, Nadkarni A, Phanasgaonkar S, Surve R, Sawant P, et al. Regional heterogeneity of beta thalassemia mutations in the multi ethnic Indian population. Blood Cells Mol Dis 2009; 42: 241-6.
31. Sinha S, Black ML, Agarwal S, Colah R, Das R, Ryan K, et al. Profiling β-thalassemia mutations in India at state and regional levels: implications for genetic education, screening and counseling programmes. Hugo J 2009; 3: 51-62.
32. Panigrahi I, Rafeeq PHA, Choudhry VP, Saxena R. High frequency of deletional α thalassemia in β thalassemia trait: Implications for genetic counselling. Am J Hematol 2004; 76: 297-99.
33. Bouva M, Harteveld C, van Delft P, Giordano P. Known and new delta globin gene mutations and their diagnostic significance. Haematologica 2006; 91: 129-32.
34. Nadkarni A, Wadia M, Gorakshakar A, Kiyama R, Colah RB, Mohanty D. Molecular charaterization of δβ thalassemia and hereditary persistence of fetal hemoglobin in the Indian population. Hemoglobin 2008; 32: 425-33.
35. Colah R, Surve R, Wadia M, Solanki, Mayekar P, Thomas M, et al. Carrier screening for β-thalassemia during pregnancy in India: A 7 year evaluation. Genet Test 2008; 12: 181-5.
36. Gorakshakar AC, Colah RB. Cascade screening for β-thalassemia: A practical approach for identifying and counseling carriers in India. Indian J Community Med 2009; 34: 354-6.
37. Sangnani B, Sukumaran PK, Mahadik C, Yagnik H, Telang S, Vaz F. et al. Thalassemia in Bombay: The role of medical genetics in developing countries. Bull World Health Organ 1990; 68: 75-81.
38. Saxena A, Phadke SR. Feasibility of thalassemia control by extended family screening in Indian context. J Health Popul Nutr 2002; 20: 31-5.
39. Cao A, Rosatelli MC, Galanello R. Control of β-thalassemia by carrier screening, genetic counseling and prenatal diagnosis- the Sardinian experience. Ciba Found Symp 1996; 197: 131-51.
40. Colah RB, Dastur AE Aras A, Pawar A, Mudera V, Gorakshakar AC. Prenatal diagnosis of thalassemia in India - The first experience. J Obstet Gynaecol India 1991; 41: 733-8.
41. Thakur Mahadik C, Vaz F, Banerjee M, Kapadia C, Natrajan PG, Yagnik H, et al. Prenatal diagnosis of β-thalassemia and other hemoglobinopathies in India. Prenat Diagn 2000; 20: 194-201.
42. Saxena R, Jain PK, Thomas E, Verma IC. Prenatal diagnosis of β-thalassemia: Experience in a developing country. Prenat Diagn 1998; 18: 1-7.
43. Gorakshakar AC, Lulla CP, Nadkarni AH, Pawar AR, Desai SN, Colah RB, et al. Prenatal diagnosis of beta thalassemia using denaturing gradient gel electrophoresis among Indians. Hemoglobin 1997; 21: 421-35.
44. Colah R, Gorakshakar A, Lu C, Nadkarni A, Desai S, Pawar A, et al. Application of covalent reverse dot-blot hybridization for rapid prenatal diagnosis of the common Indian thalassemia syndromes. Indian J Hemat Blood Transf 1997; 15: 10-3.
45. Muralitharan S, Srivastava A, Shaji RV, Mathai M, Srivastava VM, Dennison D, et al. Prenatal diagnosis of β-thalassemia mutations using the reverse dot blot technique. Natl Med J India 1996; 9: 70-1.
46. Agarwal S, Gupta A, Gupta UR, Sarwai S, Phadke S, Agarwal SS. Prenatal diagnosis in beta thalassemia: An Indian experience. Fetal Diagn Ther 2003; 18: 328-32.
47. Garewal G, Das R, Jaur J, Marwaha RK, Gupta I. Establishment of prenatal diagnosis for β-thalassemia; a step towards control in a developing country. Ann Hum Biol 2005; 32: 138-44.
48. Bandyopadhyay A, Bandyopadhyay S, Basak J, Mondal BC, Sarkar AA, Majumdar S, et al. Profile of β-thalassemia in eastern India and its prenatal diagnosis. Prenat Diagn 2004; 24: 992-6.
49. Globin Gene Server: http://globin.cse.psu.edu/, accessed on October 5, 2010.
50. Edison ES, Shaji RV, Devi SG, Moses A, Viswabandhya A, Mathews V, et al. Analysis of β-globin mutations in the Indian population: presence of rare and novel mutations and regionwise heterogeneity. Clin Genet 2008; 73: 331-7.
51. Kumar R, Tamhankar PM, Panigrahi I, Dalal A, Agarwal S. A novel β-globin mutation (HBB; c: 107 A>G; or codon 35 β(A→G) at alpha -beta chain interfaces. Ann Hematol 2009; 88: 1269-71.
52. Old JM, Varawalla NY, Weatherall DJ. The rapid detection and prenatal diagnosis of β-thalassemia in the Asian Indian and Cyproit populations in the UK. Lancet 1990; 336: 834-7.
53. Rao VB, Natrajan PG, Lulla CP, Bandodkar SB. Rapid mid-trimester prenatal diagnosis of beta-thalassaemia and other haemoglobinopathies using a non- radioactive anion exchange HPLC technique - an Indian experience. Prenat Diagn 1997; 17: 725-31.
54. Wadia MR, Phanasgaokar SP, Nadkarni AH, Surve RR, Gorakshakar AC, Colah RB, et al. Usefulness of automated chromatography for rapid fetal blood analysis for second trimester prenatal diagnosis of beta-thalassemia. Prenat Diagn 2002; 22: 153-7.
55. Rao S, Saxena R, Deka D, Kabra M. Use of HbA estimation by CE-HPLC for prenatal diagnosis of beta-thalassemia; experience from a tertiary care centre in north India: a brief report. Hematology 2009; 14: 122-4.
56. Winichagoon P, Sriphanich R, Sae-Mgo WB, Chowthaworm J, Tantisirin P, Kanokpongsakdi S, et al. Application of automated HPLC in prenatal diagnosis of thalassemia. Lab Hematol 2002; 8: 29-35.
57. Holzgreve W. Will ultrasound screening and ultrasound guided procedures be replaced by non-invasive techniques for the diagnosis of fetal chromosome anomalies? Ultrasound Obstet Gynecol 1997; 9: 217-9.
58. Steele CD, Wapner RJ, Smith JB, Haynes MK, Jackson LG. Prenatal diagnosis using fetal cells isolated from maternal peripheral blood. Clin.Obstet Gynecol 1996; 39: 801-13.
59. Mesker WE, Ouwerkerk-vn Velzen MC, Oosterwijk JC, Bernini LF, Golbus MS, Kanhai HH, et al. Two colour immunocytochemical staining of gamma and epsilon type hemoglobin in fetal red cells. Prenat Diagn 1998; 18: 1131-7.
60. Takabayashi H, Kuwabara S, Ukita T, Ikawa K, Yamafuji K, Igarashi T. Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 1995; 15: 74-7.
61. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anemia and thalassemia by analysis of fetal cells in maternal blood. Nat Genet 1996; 14: 264-8.
62. Di Naro E, Ghezzi F, Vitucci A, Tannoia N, Campanale D, D'Addario V, et al. Prenatal diagnosis of β-thalassemia using fetal erythroblasts enriched from maternal blood by a novel gradient. Mol Hum Reprod 2000; 6: 571-4.
63. Kolialexi A, Vrettou C, Traeger-Synodinos J, Burgemeister R, Papantoniou N, Kanavakis E, et al. Non invasive prenatal diagnosis of β-thalassemia using individual fetal erythroblasts isolated from maternal blood after enrichment. Prenat Diagn 2007; 27: 1228-32.
64. D'Souza E, Sawant PM, Nadkarni AH, Gorakshakar A, Mohanty D, Ghosh K, et al. Evaluation of the use of monoclonal antibodies and nested PCR for non-invasive prenatal diagnosis of hemoglobinopathies in India. Am J Clin Pathol 2008; 130: 202-9.
65. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-7.
66. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitaive analysis of fetal DNA in maternal plasma and serum: implications for non invasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-75.
67. Lun FMF, Chiu RWK, Allen Chan KC, Lau TK, Leung TY, Dennis Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008; 54: 1664-72.
68. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgrave W, Hahn S. Size separation of circulating DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004; 50: 1002-11.
69. Chiu RW, Lau TK, Leung TK, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassemia major by examination of maternal plasma. Lancet 2002; 360: 998-1000.
70. Papasavva T, Kalakoutis G, Kalikas I, Neokli E, Papacharalambous S, Kyrri A, et al. Non-invasive prenatal diagnostic assay for the detection of beta thalassemia. Ann NY Acad Sci USA 2006; 1075: 148-53.
71. Tungwiwat W, Fucharoen G, Fucharoen S, Ratanasiri T, Sanchaisuriya K, Sae-Ung N. Application of maternal plasma DNA analysis for noninvasive prenatal diagnosis of Hb E beta thalassemia. Transl Res 2007; 150: 319-25.
72. Lazaros L, Hatzi E, Bouba I, Makrydimas G, Dalkalitsis N, Stefos T, et al. Non invasive first trimester detection of paternal beta globin gene mutations and polymorphisms as predictors of thalassemia risk at chorionic villus sampling. Eur J Obstet Gynecol Repord Biol 2008; 140: 17-20.
73. Li Y, Di Naro E, Vitucci A, Grill S, Ahong XY, Holzgreve W, et al. Size fractionation of cell free DNA in maternal plasma improves the detection of a paternally inherited beta thalassemia point mutation by MALDI - TOF mass spectrometry. Fetal Diagn Ther 2009; 25: 246-9.
74. Papasavva T, Kalikas I, Kyrri A, Kleanthous M. Arrayed primer extension for the noninvasive prenatal diagnosis of beta thalassemia based on detection of single nucleotide polymorphism. Ann N Y Acad Sci USA 2008; 1137: 302-8.
75. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta thalassemia using size fractionated cell free DNA in maternal plasma. J Am Med Assoc 2005; 293: 843-9.
76. Chan K, Yam I, Leung KY, Tang M, Chan TK, Chan V. Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis in beta thalassemia: a feasibility study in southern China. Eur J Obstet Gynecol Repord Biol 2010; 150: 28-33.
77. Lo YMD. Non invasive prenatal diagnosis in 2020. Prenat Diagn 2010; 30: 702-3.